<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Homing of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells to the liver is a non-random process driven by a crosstalk between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells and components of the host tissue </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report the isolation of a <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>-specific <z:chebi fb="7" ids="16670">peptide</z:chebi> ligand (CGIYRLRSC) that binds a complex of E-cadherin and α(6) integrin on the surface of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>We identify angiopoietin-like 6 protein as a <z:chebi fb="7" ids="16670">peptide</z:chebi>-mimicked natural ligand enriched in hepatic blood vessels of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrate that an interaction between hepatic angiopoietin-like 6 and tumoural α(6) integrin/E-cadherin drives liver homing and colonization by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, and that CGIYRLRSC inhibits <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> through interference with this ligand/receptor system </plain></SENT>
<SENT sid="4" pm="."><plain>Our results indicate a mechanism for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> whereby a soluble factor accumulated in <z:mpath ids='MPATH_458'>normal</z:mpath> vessels functions as a specific ligand for circulating <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Consistently, we show that high amounts of coexpressed α(6) integrin and E-cadherin in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumours</z:e> represent a poor prognostic factor for patients with advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>